Amoxicillin Sodium — Drug Intelligence | 15 EU Trials

Filter these 15 trials by condition, phase, country and more.

Open in Search →

15 Registered trials

8 Recruiting

3 Completed trials

9 Sponsors

8 Countries

Phase III

Phase II

Phase IV

Phase III: 5 Phase II: 2 Phase IV: 7 Phase I (FiH): 1

Indications tested

Crigler-Najjar syndrome 2 Antibiotic level therapeutic 1 Implant site infection 1 Bacterial infection 1 B-cell lymphoma 1 Pyoderma 1

Sponsors using this IMP

Assistance Publique Hopitaux De Paris 5 Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevilla 2 Genethon 2 Centre Hospitalier Universitaire De Nantes 1 CHU Gabriel-Montpied 1 Instituto De Investigacion Marques De Valdecilla 1 Region Midtjylland 1 Universitair Ziekenhuis Gent 1 Uppsala Universitet 1

All trials

15 total

SHort course of Amoxicilline for eRysipElas II Pending

2024-515306-61-00 Phase IV 1 country Assistance Publique Hopitaux De Paris
AIR. ANTIBIOTIC THERAPY IN RESPIRATORY TRACT INFECTIONS A controlled randomized, open label, multicenter, non-inferiority trial evaluating a… Pending

2024-516097-30-00 Phase IV 1 country Assistance Publique Hopitaux De Paris
Defining Antibiotic Levels in Intensive care patients (DALI-2) protocol Pending

2024-516232-10-00 Phase IV 1 country Centre Hospitalier Universitaire De Nimes
PREV-CART - “A multicentric phase III randomized clinical trial open-label, comparing immunoglobulin replacement therapy (IgRT) and antibiot… Pending

2025-521571-30-00 Phase III 1 country Assistance Publique Hopitaux De Paris
Evaluation of the efficacy of treatment with autovaccines vs antibiotic treatment in subjects with hip or knee prosthesis infections. Recruiting

2024-520226-10-00 Phase III 1 country Instituto De Investigacion Marques De Valdecilla
The DALBA-study Introduction of the antibiotic dalbavancin in orthopaedic surgery – an evaluation of: • Health economic costs • Patient-repo… Recruiting

2025-522088-13-00 Phase IV 1 country Region Midtjylland
Pivmecillinam as oral step-down treatment for Escherichia coli febrile urinary tract infection versus standard of care; a randomized control… Recruiting

2023-503447-33-00 Phase II 2 countries Uppsala Universitet
Early Model-Informed Precision Dosing of beta-lactam antibiotics in critically ill children: big solution for small people? Recruiting

2024-516447-12-00 Phase IV 1 country Universitair Ziekenhuis Gent
Efficacy and safety trial of GNT0003 following imlifidase pre-treatment in participants aged 16 years and older with severe Crigler-Najjar s… Recruiting

2023-510405-18-00 Phase II 1 country Genethon
Efficacy and safety of different antimicrobial DURATions for the treatment of Infections associated with Osteosynthesis Material implanted a… Recruiting

2023-508442-18-00 Phase III 1 country Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevil…
Randomized open-label controlled trial evaluating a single-dose intravenous Dalbavancin versus standard antibiotic therapy during catheterre… Recruiting

2024-514952-34-00 Phase III 1 country Assistance Publique Hopitaux De Paris
Gene Therapy for Crigler-Najjar Syndrome Recruiting

2023-507007-60-00 Phase I (FiH) 3 countries Genethon
Clinical trial to evaluate the safety and efficacy of a 7-day versus 14-day treatment for enterococcal infections. Ended

2023-508456-18-00 Phase IV 1 country Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevil…
COTRIVAP - Efficacy of cotrimoxazole as a de-escalation treatment of Ventilator-Associated Pneumonia in intensive care unit Ended

2023-505108-52-00 Phase III 1 country Assistance Publique Hopitaux De Paris
Balloon + Oxytocin versus Oral Misoprostol to Induce labor in case of premature rupture of membranes (PROM) at term in nulliparous Ended

2022-501142-30-00 Phase IV 1 country CHU Gabriel-Montpied

Showing 1–15 of 15 trials

← All drugs A–Z